Suppr超能文献

疏肝健脾方对非酒精性脂肪性肝病大鼠肝细胞中SREBP-1c、SCD-1 mRNA及蛋白表达的影响

[Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats].

作者信息

Xu Yong-jian, Yang Qin-he, Han Li, Zhang Yu-pei, Liu Yi-zhen, Jin Ling, Yan Hai-zhen

出版信息

Zhong Yao Cai. 2014 Jan;37(1):80-6.

Abstract

OBJECTIVE

To observe the effects of soothing liver and invigorating spleen recipes on the expression levels of SREBP-1c, SCD-1 mRNA and proteins in hepatocytes of NAFLD rats,and to explore its possible mechanisms of prevention and treatment of NAFLD.

METHODS

75 SD male rats were randomly divided into 5 groups: normal group, model group, oothing liver group (administrated with 9.6 g/kg), invigorating spleen group (administrated with 30 g/kg)and integrated group (administrated with 39.6 g/kg). The rats of NASH model were induced by feeding a high-fat diet. After treatment for 8 weeks,9 rats were randomly taken to detect liver function, TC, TG and pathological changes in liver tissue. The other 6 rats of each group were taken respectively and collagenase (Type IV) was perfused to digest liver tissue with the circulation in vitro to separate hepatocytes. Real-time Q-PCR and Western Blot were used to detect the expression levels of SREBP-1c, SCD-1 mRNA and proteins.

RESULTS

Compared with the model group,the different decrease levels of SREBP-1c, SCD-1 genes and proteins were found in all drug therapy groups (P < 0.05 or P < 0.01), as well different degrees that liver lipid and pathological changes became better, especially that of in soothing liver group. Comparison between the all drug therapy groups,the hepatocytes expression levels of SREBP-1c and SCD-1 mRNA in soothing liver group were lower than that of in invigorating spleen group (P < 0.05), but expression levels of the proteins had no statistical significances.

CONCLUSION

Soothing liver and invigorating spleen recipes prevent and treat NAFLD,its mechanism may be related to inhibiting the activation of SREBP-1c/SCD-1 signal pathway in hepatocytes to down-regulate TC and TG synthesis and reduce hepatic lipid deposition. SREBP-1c, SCD-1 mRNA and proteins may be the effective targets.

摘要

目的

观察疏肝健脾方对非酒精性脂肪性肝病(NAFLD)大鼠肝细胞中SREBP-1c、SCD-1 mRNA及蛋白表达水平的影响,探讨其防治NAFLD的可能机制。

方法

将75只雄性SD大鼠随机分为5组:正常组、模型组、疏肝组(给予9.6 g/kg药物)、健脾组(给予30 g/kg药物)和综合组(给予39.6 g/kg药物)。采用高脂饮食诱导大鼠建立NASH模型。治疗8周后,随机取9只大鼠检测肝功能、总胆固醇(TC)、甘油三酯(TG)及肝组织病理变化。每组另取6只大鼠,分别用IV型胶原酶灌注消化肝组织并进行体外循环以分离肝细胞。采用实时荧光定量聚合酶链反应(Real-time Q-PCR)和蛋白质免疫印迹法(Western Blot)检测SREBP-1c、SCD-1 mRNA及蛋白表达水平。

结果

与模型组比较,各药物治疗组SREBP-1c、SCD-1基因及蛋白表达水平均有不同程度降低(P<0.05或P<0.01),肝脂质及病理变化均有不同程度改善,尤以疏肝组明显。各药物治疗组比较,疏肝组肝细胞SREBP-1c、SCD-1 mRNA表达水平低于健脾组(P<0.05),但蛋白表达水平差异无统计学意义。

结论

疏肝健脾方可防治NAFLD,其机制可能与抑制肝细胞中SREBP-1c/SCD-1信号通路的激活,下调TC和TG合成,减少肝脏脂质沉积有关。SREBP-1c、SCD-1 mRNA及蛋白可能是其有效的作用靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验